Loading...

BIIB BIOGEN INC Capital Structure Changes 8-K Filing

BGN

BB

BIOGEN INC

(BIIB)

2026 8-K

Biogen Merger Announcement

Management Change

Financial Results Released

Financial Update

Q3 Earnings Report

Financial Update

Earnings Releases

Other Special Situation

Debt-Equity Swaps

Financial Statements

Financial Results

Earnings Report

Q3 Financial Results

Earnings Report

Earnings Report

Earnings Reports

Filing Letter with Quantita...

Earnings Reports

Earnings Reports

Filing Letter with Quantita...

Earnings Reports

Acquisition Completed

Credit Agreement for Acquis...

Merger Agreement

Merger Agreement

Earnings Releases

Filing with Quantitative Data

Quantitative Data

Earnings Report

External Links:

Biogen Inc. reported an expected expense of approximately $222 million related to research and development for the fourth quarter of 2025, impacting earnings by about $1.26 per diluted share as of January 13, 2026.

AI Assistant

BIOGEN INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.